Title : Phase II study of the tetrahydropyranyl adriamycin-cyclophosphamide, vincristine, and prednisolone regimen combined with rituximab as first-line treatment for elderly patients with diffuse large B-cell lymphoma.

Pub. Date : 2011 Apr

PMID : 21438831






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We previously described the benefit of the THP-COP regimen comprising cyclophosphamide, THP, vincristine, and prednisolone for elderly patients with diffuse large B-cell lymphoma (DLBCL). Cyclophosphamide caspase recruitment domain family member 16 Homo sapiens